Abstract
Objective:
To propose a protocol for minimizing medical complications associated with the use of cyproterone, medroxyprogesterone, and depot leuprolide to treat paraphilia.
Method:
Review of the relevant literature.
Results:
Certain patient populations should not be treated with these medications, and medical complications associated with each can be detected early and avoided.
Conclusions:
For each drug, a series of screening tests prior to use and scheduled testing during use can minimize potential medical complications.
MeSH terms
-
Administration, Oral
-
Androgen Antagonists / administration & dosage*
-
Androgen Antagonists / adverse effects
-
Cyproterone Acetate / administration & dosage*
-
Cyproterone Acetate / adverse effects
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Humans
-
Injections, Intramuscular
-
Leuprolide / administration & dosage*
-
Leuprolide / adverse effects
-
Male
-
Medroxyprogesterone / administration & dosage*
-
Medroxyprogesterone / adverse effects
-
Paraphilic Disorders / diagnosis
-
Paraphilic Disorders / drug therapy*
-
Paraphilic Disorders / psychology
Substances
-
Androgen Antagonists
-
Cyproterone Acetate
-
Leuprolide
-
Medroxyprogesterone